Lacosamide: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Lacosamide. Educational only — not medical advice.
Labeled uses
VIMPAT is indicated for the treatment of partial-onset seizures in patients 4 years of age and older. As the safety of VIMPAT injection in pediatric patients has not been established, VIMPAT injection is indicated for the treatment of partial-onset seizures only in adult patients (17 years of age and older).
Source: FDA labeling via NIH DailyMed (set 42b3cf1d…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.